Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Experimental Eye Research
|
July 20, 2023
Untargeted metabolomics in the aqueous humor reveals the involvement of TAAR pathway in glaucoma
Lakshminarayanan Gowtham, Nabanita Halder, Dewang Angmo, et al.
International Journal of Retina and Vitreous
|
November 22, 2018
Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril
Madhu Nath, Nabanita Halder, Parijat Chandra, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
September 9, 2019
Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits
Santosh Kumar Patnaik, Nabanita Halder, Bhavna Chawla, et al.
Indian Journal of Physiology and Pharmacology
|
June 30, 2018
Evaluation of the Protective Effect of NMDA/Non-NMDA Receptor Antagonists Against Ethambutol Induced Retinal Toxicity Using ERG in Wistar Rats
A R Vijayakumar, H Anuradha, Nihar Ranjan Biswas, et al.
Indian Journal of Physiology and Pharmacology
|
May 30, 2018
Fabrication and Validation of Gyro-Dot-Optomotor Response Device using Gold Fish to Study Drugs Affecting Visual Perception
Arumugam Ramamoorthy Vijayakumar, Nihar Ranjan Biswas, Vimla Menon, et al.
Plos One
|
December 30, 2016
Involvement of Renin-Angiotensin System in Retinopathy of Prematurity - A Possible Target for Therapeutic Intervention
Madhu Nath, Parijat Chandra, Nabanita Halder, et al.
Investigative Ophthalmology & Visual Science
|
June 7, 2022
Retinal Pigment Epithelium in Human Donor Eyes Contains Higher Levels of Bisretinoids Including A2E in Periphery than Macula
Ankita Kotnala, Srinivasan Senthilkumari, Gong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Jing Deng, Aneel Paulus, Douglas D Fang, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Experimental Eye Research
|
July 20, 2023
Untargeted metabolomics in the aqueous humor reveals the involvement of TAAR pathway in glaucoma
Lakshminarayanan Gowtham, Nabanita Halder, Dewang Angmo, et al.
International Journal of Retina and Vitreous
|
November 22, 2018
Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril
Madhu Nath, Nabanita Halder, Parijat Chandra, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
September 9, 2019
Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits
Santosh Kumar Patnaik, Nabanita Halder, Bhavna Chawla, et al.
Indian Journal of Physiology and Pharmacology
|
June 30, 2018
Evaluation of the Protective Effect of NMDA/Non-NMDA Receptor Antagonists Against Ethambutol Induced Retinal Toxicity Using ERG in Wistar Rats
A R Vijayakumar, H Anuradha, Nihar Ranjan Biswas, et al.
Indian Journal of Physiology and Pharmacology
|
May 30, 2018
Fabrication and Validation of Gyro-Dot-Optomotor Response Device using Gold Fish to Study Drugs Affecting Visual Perception
Arumugam Ramamoorthy Vijayakumar, Nihar Ranjan Biswas, Vimla Menon, et al.
Plos One
|
December 30, 2016
Involvement of Renin-Angiotensin System in Retinopathy of Prematurity - A Possible Target for Therapeutic Intervention
Madhu Nath, Parijat Chandra, Nabanita Halder, et al.
Investigative Ophthalmology & Visual Science
|
June 7, 2022
Retinal Pigment Epithelium in Human Donor Eyes Contains Higher Levels of Bisretinoids Including A2E in Periphery than Macula
Ankita Kotnala, Srinivasan Senthilkumari, Gong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Jing Deng, Aneel Paulus, Douglas D Fang, et al.
Page
of 4